$69M IPO Filed By Biotech That Uses AI To Develop Drugs
BioXcel Therapeutics Inc., a company using artificial intelligence to develop drugs that fight cancer and neurological disorders, on Monday filed an initial public offering estimated to raise $69 million, joining an...To view the full article, register now.
Already a subscriber? Click here to view full article